Status:
COMPLETED
Intraoperative Insulin Administration at Cardiac Surgery for Diabetic Patients
Lead Sponsor:
The Hashemite University
Conditions:
Diabetes Mellitus
Cardiac Event
Eligibility:
All Genders
40-70 years
Phase:
PHASE4
Brief Summary
The primary objective of the study was to explore which insulin-based regimen is better, infusion or bolus regimen, for intraoperative management of glucose level for the diabetic patient at cardiac s...
Detailed Description
The primary objective of the study was to explore which insulin-based regimen is better, infusion or bolus regimen, for intraoperative management of glucose level for the diabetic patient at cardiac s...
Eligibility Criteria
Inclusion
- Diabetic patients, type 2, who were admitted to hospital for cardiac surgery.
- Patient above 40 years old,
- Patients who need the usual insulin according to insulin dosing guidelines
- Patients with pre-operation glucose level \> 200 mg/dL and \< 300 mg/dL.
Exclusion
- Insulin sensitive patents (Age \>70 years, Glomerular Filtration Rate (GFR) \<45 ml/min, No history of Diabetes, Insulin resistance patients (Body Mass Index \> 35 kg/m2, total daily insulin dose \>80 units, Steroids \> 20 mg prednisone daily, patients who at high risk of complications and or (those whom their operation was differed to be supervised by a specialized team).
- Patients who were unable to give written informed consent.
- Patients have ≥4 emergency admissions during the six months prior to the index admission.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT04824586
Start Date
June 1 2019
End Date
January 30 2020
Last Update
April 1 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Prince Hamza Hospital
Amman, Jordan